drugset / Trial / NCT05104099

Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia

NCT05104099

Phase 2 Completed 17 enrolled Institut de Cancérologie de Lorraine
NaSingle-groupOpen-labelDiagnostic

Summary

This study is a single-center propsective clinical trial to assess the ability of fluorescence techniques to mark high-grade vulvar intraepithelial neoplasias including high-grade vulvar squamous intraepithelial lesions and differentiated vulvar intraepithelial neoplasias following 3 hours Metvixia application.

Timeline

Start
2021-11-29
Primary completion
2024-06-27
Completion
2025-05-25

Drugs

EvaluationDrugModalityDoseRoute
Subject methyl aminolevulinate Small molecule Topical